Clinical Trials · NCT07756359

Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)

Name: Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

Not Yet RecruitingPhase 4Tirzepatide

Phase: Phase 4
Recruitment status: Not Yet Recruiting
Sponsor: University of North Carolina, Chapel Hill
Enrollment: 20
Start date: Sep 2026
Locations: 5 sites, United States
Primary endpoint: Proportion of patients achieving a decrease of the average daily bowel frequency by 30% at week 12 (Week 16 if applicable)

View Tirzepatide compound reference